Related Experiment Video
Updated: Sep 6, 2025

Cell-based Calcium Assay for Medium to High Throughput Screening of TRP Channel Functions using FlexStation 3
Published on: August 17, 2011
The calcium channel terminator: hasta la vista pain
Erika K Harding1, Gerald W Zamponi1
1Department of Physiology and Pharmacology, Alberta Children's Hospital Research Institute, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Abstract:
Chronic pain remains a major burden and is difficult to treat. N-type calcium channels may be a suitable therapeutic target for analgesics, and a new study from Colecraft and colleagues utilizes a clever new way to modulate their expression to achieve therapeutic benefits in preclinical models of neuropathic pain.
Insights
New research targets N-type calcium channels for chronic pain relief. Modulating these channels shows therapeutic benefits in preclinical neuropathic pain models, offering hope for novel analgesic development.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Chronic pain presents a significant global health challenge with limited effective treatments.
- N-type calcium channels are implicated in pain signaling and represent a potential therapeutic target for analgesics.
Purpose of the Study:
- To explore a novel strategy for modulating N-type calcium channel expression.
- To evaluate the therapeutic efficacy of this approach in preclinical models of neuropathic pain.
Main Methods:
- Development of a novel method to modulate N-type calcium channel expression.
- Preclinical testing in established models of neuropathic pain.
Main Results:
- The novel modulation strategy successfully altered N-type calcium channel expression.
- Significant therapeutic benefits were observed in preclinical models, indicating analgesic potential.
Conclusions:
- Modulating N-type calcium channel expression is a promising therapeutic avenue for chronic pain.
- This study provides a foundation for developing new analgesics targeting these channels.
Related Concept Videos
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Analgesia and Pain Management
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Pain

